London, United Kingdom

Eric Michael Bergman

This inventor holds 1 USPTO granted patent. Top assignee: Ori Biotech Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Michael Bergman. Retrieved from https://idiyas.com/inventor/eric-michael-bergman-4dvac8h6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Celebrating the Innovations of Eric Michael Bergman

Introduction: Eric Michael Bergman is a notable inventor based in London, GB, recognized for his innovative contributions in the field of biotechnology. With a strong focus on advancing bioreactor technology, Eric has developed a patent that showcases his commitment to enhancing scientific processes.

Latest Patents: Eric holds one patent for a bioreactor, which represents a significant advancement in the biotechnology sector. This invention is designed to optimize the cultivation of cells, which can have profound implications for research and therapeutic applications.

Career Highlights: Currently, Eric is employed at Ori Biotech Ltd., a company dedicated to transforming cell and gene therapies. His work at Ori is instrumental in pushing the boundaries of biotechnological innovation, driving progress within the industry.

Collaborations: Eric collaborates with talented individuals such as William Raimes and Vincent Gowler. Their combined efforts contribute to the success of their projects and the overall innovation within the company.

Conclusion: Eric Michael Bergman’s contributions to the field of biotechnology, particularly through his patented bioreactor technology, exemplify his role as a forward-thinking inventor. His collaborations and work at Ori Biotech Ltd. continue to foster advancements that hold the promise of transforming the landscape of therapeutic innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…